Induction Therapy With a Combination of Weekly Adalimumab Plus Intensive Granulocyte and Monocyte Adsorptive Apheresis in Patients With Ulcerative Colitis and Failure of Conventional Agents, Biologics and Janus Kinase Inhibitor

Every-week (ew) adalimumab (ADA) maintenance following induction therapy with a standard induction regimen has recently been approved for use in Japan. The efficacy and safety of combination therapy with ew-ADA maintenance following standard induction regimen plus intensive granulocyte and monocyte...

Descripción completa

Detalles Bibliográficos
Autores principales: Tanida, Satoshi, Ozeki, Keiji, Katano, Takahito, Tanaka, Mamoru, Shimura, Takaya, Kubota, Eiji, Kataoka, Hiromi, Takahama, Takuya, Sasoh, Shun, Kubota, Yoshimasa, Ban, Tesshin, Ando, Tomoaki, Nakamura, Makoto, Joh, Takashi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elmer Press 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10079367/
https://www.ncbi.nlm.nih.gov/pubmed/37035853
http://dx.doi.org/10.14740/jocmr4887

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10079367/
https://www.ncbi.nlm.nih.gov/pubmed/37035853
http://dx.doi.org/10.14740/jocmr4887

Ejemplares similares